BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jakabova A, Bielcikova Z, Pospisilova E, Petruzelka L, Blasiak P, Bobek V, Kolostova K. Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy. Ther Adv Med Oncol 2021;13:17588359211028492. [PMID: 34345252 DOI: 10.1177/17588359211028492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Chang KT, Thompson KN, Pratt SJP, Ju JA, Lee RM, Mathias TJ, Mull ML, Annis DA, Ory EC, Stemberger MB, Vitolo MI, Martin SS. Elevation of Cytoplasmic Calcium Suppresses Microtentacle Formation and Function in Breast Tumor Cells. Cancers 2023;15:884. [DOI: 10.3390/cancers15030884] [Reference Citation Analysis]
2 Vasantharajan SS, Barnett E, Gray ES, Rodger EJ, Eccles MR, Pattison S, Munro F, Chatterjee A. Size-Based Method for Enrichment of Circulating Tumor Cells from Blood of Colorectal Cancer Patients. Methods Mol Biol 2023;2588:231-48. [PMID: 36418692 DOI: 10.1007/978-1-0716-2780-8_15] [Reference Citation Analysis]
3 Adity A. Pore, Swastika S. Bithi, Mina Zeinali, Hunaiz Bin Navaid, Sunitha Nagrath, Rakhshanda Layeequr Rahman, Siva A. Vanapalli. Phenotyping of rare circulating cells in the blood of non-metastatic breast cancer patients using microfluidic Labyrinth technology. Biomicrofluidics 2022;16:064107. [PMID: 36536791 DOI: 10.1063/5.0129602] [Reference Citation Analysis]
4 Freitas AJAD, Causin RL, Varuzza MB, Calfa S, Hidalgo Filho CMT, Komoto TT, Souza CDP, Marques MMC. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer. IJMS 2022;23:9952. [DOI: 10.3390/ijms23179952] [Reference Citation Analysis]
5 Liu X, Tao M. SSX2IP as a novel prognosis biomarker plays an important role in the development of breast cancer. Mol Cell Toxicol 2022. [DOI: 10.1007/s13273-022-00273-7] [Reference Citation Analysis]
6 Wang D, Dong R, Wang X, Jiang X. Flexible Electronic Catheter Based on Nanofibers for the In Vivo Elimination of Circulating Tumor Cells. ACS Nano 2022. [PMID: 35302351 DOI: 10.1021/acsnano.1c09807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rupp B, Ball H, Wuchu F, Nagrath D, Nagrath S. Circulating tumor cells in precision medicine: challenges and opportunities. Trends in Pharmacological Sciences 2022. [DOI: 10.1016/j.tips.2022.02.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]